Product Information

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Sandoz Inc., priced at $0.1919 per EA under NDC 00185021101. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Benazepril Hydrochloride and Hydrochlorothiazide
$0.1919per EA

Strength

20; 12.5 mg/1; mg/1

Manufacturer

Sandoz Inc.

NDC

00185021101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076631

FDA Approved

2/11/2004

TE Code

AB

On Market Since

2/11/2004

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1919 per EA
All-time high$1.5116 (Mar 12, 2014)
All-time low$0.1503 (Nov 20, 2024)
52-week high$0.2705
52-week low$0.1742
Median price$0.6092
Average price$0.7140
Largest weekly change+56.5% (Oct 18, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+10.1%

1M

+10.1%

3M

+3.0%

6M

+0.6%

1Y

-29.1%

3Y

-50.6%

5Y

-64.8%

All

-84.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Sandoz Inc., is $0.1919 per EA (NDC 00185021101), effective Aug 19, 2026.

How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 84.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Nov 28, 2013, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1503 (Nov 20, 2024) to a high of $1.5116 (Mar 12, 2014), with a median of $0.6092 per EA.

Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 00185021101) is labeled by Sandoz Inc., and CMS classifies it as a generic product.